Literature DB >> 27013173

Differential regulation of T-cell dependent and T-cell independent antibody responses through arginine methyltransferase PRMT1 in vivo.

Kikumi Hata1, Noriko Yanase1, Katsuko Sudo2, Hiroshi Kiyonari3,4, Yoshiko Mukumoto4, Junichiro Mizuguchi1, Tadashi Yokosuka1.   

Abstract

Protein arginine methyltransferase 1 (PRMT1), a major PRMT in mammalian cells, has been shown to play a crucial role in multiple biological functions in vitro. To explore the role of PRMT1 in B cells in vivo, we generated B cell-specific PRMT1-deficient (Prmt1(-/-) ) mice using a Cre-loxP system. Prmt1(-/-) mice showed a defect in B-cell development with diminished levels of serum antibodies. Antibody responses in Prmt1(-/-) mice were absent after stimulation with the type 2 T cell-independent antigen NP-Ficoll but intact after stimulation with the T cell-dependent antigen NP-OVA. Our findings comprise the first evidence showing that PRMT1 is necessary for lymphocyte functions in vivo.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  B cells; PRMT; T-dependent antigen; T-independent antigen; antibody response; arginine methylation

Mesh:

Substances:

Year:  2016        PMID: 27013173     DOI: 10.1002/1873-3468.12161

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex.

Authors:  Elmar Dolezal; Simona Infantino; Friedel Drepper; Theresa Börsig; Aparajita Singh; Thomas Wossning; Gina J Fiala; Susana Minguet; Bettina Warscheid; David M Tarlinton; Hassan Jumaa; David Medgyesi; Michael Reth
Journal:  Nat Immunol       Date:  2017-06-19       Impact factor: 25.606

Review 2.  The Influence of Arginine Methylation in Immunity and Inflammation.

Authors:  Nivine Srour; Sarah Khan; Stephane Richard
Journal:  J Inflamm Res       Date:  2022-05-13

Review 3.  Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.

Authors:  Weijing Dai; Jianguo Zhang; Siqi Li; Fajian He; Qiao Liu; Jun Gong; Zetian Yang; Yan Gong; Fang Tang; Zhihao Wang; Conghua Xie
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

4.  Protein Arginine Methyltransferase 1 (PRMT1) Selective Inhibitor, TC-E 5003, Has Anti-Inflammatory Properties in TLR4 Signaling.

Authors:  Eunji Kim; Jiwon Jang; Jae Gwang Park; Kyung-Hee Kim; Keejung Yoon; Byong Chul Yoo; Jae Youl Cho
Journal:  Int J Mol Sci       Date:  2020-04-26       Impact factor: 5.923

5.  Protein arginine methyltransferase 1 is required for maintenance of normal adult hematopoiesis.

Authors:  Lei Zhu; Xin He; Haojie Dong; Jie Sun; Hanying Wang; Yinghui Zhu; Feiteng Huang; Jingying Zou; Zexin Chen; Xiaoying Zhao; Ling Li
Journal:  Int J Biol Sci       Date:  2019-10-23       Impact factor: 6.580

6.  Arginine methylation catalyzed by PRMT1 is required for B cell activation and differentiation.

Authors:  Simona Infantino; Amanda Light; Kristy O'Donnell; Vanessa Bryant; Danielle T Avery; Michael Elliott; Stuart G Tangye; Gabrielle Belz; Fabienne Mackay; Stephane Richard; David Tarlinton
Journal:  Nat Commun       Date:  2017-10-12       Impact factor: 14.919

7.  PRMT5 is essential for B cell development and germinal center dynamics.

Authors:  Ludivine C Litzler; Astrid Zahn; Alexandre P Meli; Steven Hébert; Anne-Marie Patenaude; Stephen P Methot; Adrien Sprumont; Thérence Bois; Daisuke Kitamura; Santiago Costantino; Irah L King; Claudia L Kleinman; Stéphane Richard; Javier M Di Noia
Journal:  Nat Commun       Date:  2019-01-03       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.